France-based Axa Venture Partners, a venture capital subsidiary of insurance company AXA, is securing a 130 million euros ($150 million) early-stage fund, AVP Early Stage II.
With AVP Early Stage II, Axa Venture Partners intends to commit in early-stage startups based in North America, Europe and Israel.
Axa Venture Partners will commit up to $6 million per company. The firm has bagged a total of $227.2 million in a single venture fund.
The company generates $250 million in revenue annually.